Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing
Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Total Hip Resurfacing; Arthroplasty, Replacement, Hip
Phase: N/A
Status: Recruiting
Sponsored by: Biomet, Inc. Overall contact:
Gregoire Edorh, Phone: + 33 (0)4 75 75 91 19, Email: gregoire.edorh@biomet.com
Summary
This observational study intends to collect efficacy and safety data on ReCap/Magnum in
Total Hip Replacement and Resurfacing.
Clinical Details
Official title: A Prospective, Multicentre Study Evaluating the Clinical Performance of the ReCap/Magnum in Total Hip Replacement and Resurfacing
Study design: Cohort, Prospective
Primary outcome: Postel-Merle d'Aubigné (PMA), Harris Hip Score
Secondary outcome: ComplicationSurvival
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
Consecutive series of patients received Total Hip Replacement or Resurfacing with
ReCap/Magnum for Its Respective Indications for Use/Intended Uses
Locations and Contacts
Gregoire Edorh, Phone: + 33 (0)4 75 75 91 19, Email: gregoire.edorh@biomet.com
CHU Pellegrin Tripode, BORDEAUX, France; Recruiting
Dominique CHAUVEAUX, MD, Phone: 05 56 79 56 79
Dominique Chauveaux, Ph - MD, Principal Investigator
Polyclinique de Hénin Beaumont, Henin-beaumont, France; Recruiting
Sylvain GUERIOT, MD, Phone: 03.21.13.31.90
Sylvain GUERIOT, MD, Sub-Investigator
Philippe STAHL, MD, Principal Investigator
CHU Hôpital Sud, Grenoble, France; Recruiting
Dominique Saragaglia, Ph - MD
Dominique Saragaglia, Ph-MD, Principal Investigator
Polyclinique de Riaumont, LIEVIN, France; Recruiting
Didier Ghestem, MD
Didier Ghestem, MD, Principal Investigator
Clinique Saint Andre, Reims, France; Recruiting
Marc Ameil, MD
Marc Ameil, MD, Sub-Investigator
Additional Information
Starting date: March 2008
Ending date: February 2014
Last updated: June 18, 2009
|
